- The Peel
- Posts
- Markets Catch A Break
Markets Catch A Break
Oil prices fall after the U.S. and Iran agree to continue talks and keep the Strait of Hormuz open.

Your Daily Dose of Market & Career Clarity
đŹ Delivered to 150,000+ ambitious readers
Silver banana goes toâŠ
Get a Top Job Offer, Guaranteed (or tuition is free) | Apply Here
Market Snapshot

đ Banana Bits
Big Tech drags the Nasdaq lower as Alphabet, Amazon, Meta, and Microsoft all retreat.
Alphabet loses significant market value following the departures of two prominent AI leaders.
Oil prices fall after the U.S. and Iran agree to continue talks and keep the Strait of Hormuz open.
The Nasdaq-100 announces a major reshuffle that brings in several AI-linked companies.
Supermicro surges after Nvidia names it as a builder for its Vera Rubin systems.
Market News
Brains, Bonds, and Barrels
It was a split tape with a clear dividing line. The Dow closed up 0.29% (+148 points) while the S&P 500 slipped 0.37% to 7,472.79 and the Nasdaq Composite dropped 1.32% to 26,166.60.
The rule of the day was simple: anything with âAIâ stapled to its forehead got sold, while industrials, energy-adjacent value, and small caps threw a party⊠the Russell 2000 notching a record and brushing the 3,000 mark for the first time.
The headline villain was Alphabet, down about 5% in its worst session in roughly a year and hemorrhaging an estimated $250 billion in market value. The cause wasnât earnings or regulation but an exodus of human capital. Gemini co-lead Noam Shazeer left for OpenAI, and Nobel-winning DeepMind scientist John Jumper defected to Anthropic.
Alphabet is raising $84.75 billion in equity (up from an initial ~$80B proposal) to bankroll an AI capex bill running $180â190 billion this year, and it wasn't alone in the red: Amazon (â4.8%), Meta (â2.3%), and Microsoft (â3%) all joined the slide.
Then there was SpaceX, the marketâs newest celebrity, which fell 16% for a third straight loss. Fresh off the largest IPO in history ($75 billion, $85.7 billion after the greenshoe) and a $60 billion all-stock grab of AI coding startup Cursor, the company is now selling $20 billion-plus in bonds, earmarked to refinance bridge debt and for general corporate purposes.
With only a razor-thin ~4-5% of shares in the public float, every headline swings the stock like a kettlebell, and a rock-bottom ESG grade from MSCI didnât exactly steady the hand.

Macro, at least, gave equities some cover. U.S.-Iran negotiators left Switzerland with a 60-day "road map" and a pledge to keep the Strait of Hormuz flowing, sending WTI below $74 and Brent toward $78.
Cheaper oil is wonderful for almost everyone⊠except the inflation hawks now running the Fed. Chair Kevin Warsh's first FOMC meeting held rates at 3.5-3.75% but nudged the 2026 core PCE forecast up to 3.3%, and markets are now openly considering the once-unthinkable: a rate hike. Thursday's PCE print (June 25) is the next gut-check.
Add the Nasdaq-100âs quarterly reshuffle swapping legacy names for CoreWeave, Rocket Lab, and friends, and you get a market quietly rotating out of yesterdayâs winners. Breadth was actually healthy on Monday. It just wasnât where the cameras were pointed.
Peel Take: Monday wasnât a tech apocalypse but a reminder that mega-cap valuations are priced for flawless execution, and âour genius just quitâ is the opposite of flawless. The bullish read: money didnât flee the market; it rotated into small caps, industrials, and the new index kids. The bearish read: the AI trade is starting to resemble an arms race where everyone spends $100B+, and nobodyâs allowed to ask about the receipts. Weâre not calling a top, but when one company runs a record IPO, drops $60B on a startup, and then lines up $20B in bonds, all in a single month, that's not confidence. Thatâs a caffeine addiction. Buckle up through Thursday.
What's Ripe
Definium Therapeutics (DFTX) 49.8%
Its Phase 3 "Emerge" study of DT120, an orally disintegrating tablet for major depressive disorder, hit its primary endpoint and every key secondary one. The data carried real weight: an 8.1-point placebo-adjusted improvement on the standard depression scale at week 6, with a p-value below 0.0001, statistician-speak for "this almost certainly isn't luck."
About 99% of side effects were mild to moderate, and the company held $373.4M in cash (as of Mar. 31, 2026), plus access to up to $120M under a credit facility, a comfortable multi-year cushion for a clinical-stage name.
Peel Take: Binary biotech days are the closest the market gets to a scratch-off ticket, and DFTX just hit. Set the stock aside for a second, though; a clean Phase 3 readout in depression is a genuinely meaningful result for patients, not just shareholders, and that deserves respect. The investor catch is the usual one: the science still has to clear the FDA, and "approvable" and "profitable" live in different zip codes. And one more wrinkle: after Monday's close, Definium announced a proposed public stock offering, striking while the iron's hot, but a fresh dilution headwind to watch at the open. Enjoy the pop, but remember biotech giveth and biotech taketh away, often before lunch.
Super Micro Computer (SMCI) 15.7%
NVIDIA unveiled its next-gen Vera Rubin platform in Hamburg and named Supermicro among multiple system builders, including Dell, HPE, and Lenovo, effectively a front-row seat to the next AI hardware cycle. GF Securities upgraded the stock from hold to buy with a $48 price target.
Softer oil, courtesy of the Iran de-escalation, eases the energy math on the giant data-center buildouts SMCI feeds.
Peel Take: SMCI is the market's mood ring for AI hardware hype; when NVIDIA sneezes, Supermicro catches either a cold or a rocket, with no in-between. Monday, it caught the rocket. Just keep two things in mind: this is the same company that gave investors accounting-related heartburn not long ago, and it recently raised $7B, diluting holders. A glowing partner announcement is fuel, not a clean bill of health. Ride it with your eyes open.
What's Rotten
SpaceX (SPCX) 16.43%
Third straight down day, this time after unveiling a $20B+ bond sale (to refinance bridge debt and for general corporate purposes), fresh off a record IPO ($75B, $85.7B with the greenshoe) and a $60B all-stock deal for Cursor.
A tiny ~4-5% public float means even modest selling sends the price flying; thin liquidity cuts both ways. MSCI handed it the lowest possible ESG rating (CCC), with a 1-out-of-10 controversies score for extra seasoning.
Peel Take: SpaceX is a genuinely incredible company strapped to one of the wildest tickers ever floated. When ~95% of your shares are locked up, the stock isnât really a stock; itâs a dinghy in a big harbor, and Monday a yacht motored past. The capital-raising spree (a record IPO, a $60B startup deal, and now $20B in bonds, all in one month) is either visionary land-grabbing or a balance sheet doing parkour. Honestly, probably both. Not for the faint of heart or the thin of stomach.
Alphabet (GOOGL) 5.0%
Worst day in roughly a year, shedding an estimated $250B in market cap, after two marquee AI researchers walked: Noam Shazeer to OpenAI and Nobel laureate John Jumper to Anthropic.
The exits spotlight a brutal talent war in which rivals will pay almost anything for the right brains. Layered on top: an $84.75B equity raise and a $180â190B AI capex bill that have investors questioning the timeline to payoff.
Peel Take: Google has the data, the distribution, and a mountain of cash, but talent is the one asset that can quit and walk across the street, and lately it keeps doing exactly that. Losing your Gemini co-lead and a Nobel winner in the same week is a brutal look. That said, one ugly week doesnât unwind a search-and-cloud empire; the real worry isnât these two resumes; itâs whether the âspend whatever it takesâ AI era ever shows up in the profit line. Cheap, it is not.
đ§ Technical Trip
Interview Q&A from PJT Partners

đ Want 1-on-1 recruiting help from PJT Partners bankers & 2,000+ top mentors? Apply to WSO Academy
đ Lesson from the Library
đ„ Financial Planning & Analysis: Drive Better Business Decisions
Master budgeting, forecasting, and financial analysis to drive smarter business decisions.
đŠ Deal Dispatch
M&A, IPOs, And Other Notable Transactions
CRH agrees to acquire Arcosa in an all-cash infrastructure deal.
SpaceX launches its first bond offering following its blockbuster public debut.
Bending Spoons moves ahead with plans for a major U.S. IPO.
RWE expands its grid business with a deal for majority control of Amprion.
Castlelake takes its bid for easyJet public after multiple takeover approaches are rejected.
đThe Daily Poll
Alphabet, Amazon, Meta, and Microsoft all fell. Which Big Tech company would you be most likely to invest in today? |
Previous Poll:
Emerging-market stocks hit record highs. Have you ever invested outside your home country?
Yes, regularly: 23.3% // A little: 33.4% // Not yet, but interested: 23.3% // No interest: 20.0%
Banana Brain Teaser
Previous
If y is the smallest positive integer such that 3,150 multiplied by y is the square of an integer, then y must be?
Answer: 14
Today
In a small snack shop, the average (arithmetic mean) revenue was $400 per day over a 10-day period. During this period, if the average daily revenue was $360 for the first 6 days, what was the average daily revenue for the last 4 days?
Iâd be a bum on the street with a tin cup if the markets were always efficient.
How Would You Rate Today's Peel?
Happy Investing,
Chris, Ankit, Mitchell, Fernanda, Nick, & Patrick


